Meanwhile, DZ2002 treatment significantly reduced collagen content and mRNA expression of the Col1a1 and Col1a2 while promoting that of the matrix metalloproteinase-13 (MMP-13) in the lesional skin of BLM-induced mice (Fig. 1e). Here, COL1A2 is linked to Bloom syndrome.